EUVIMEDEUVIMED entdecken
Fallbericht

Survival of Transplanted Allogeneic Beta Cells with No Immunosuppression

Per-Ola Carlsson, Xiaomeng Hu, Hanne Scholz, Sofie Ingvast, Torbjörn Lundgren, Tim Scholz, Olof Eriksson, Per Liss, Di Yu, Tobias Deuse, Olle Korsgren iD, Sonja Schrepfer

New England Journal of Medicine · 04.09.2025 · 393 (9) · 887-894

DOI: 10.1056/nejmoa2503822 ↗

Kurz gefasst

Fallbericht in der Zeitschrift New England Journal of Medicine, erschienen am 04.09.2025. Verfasst von Per-Ola Carlsson und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Graft Survival, Islets of Langerhans Transplantation, Graft Rejection. Die Arbeit wurde bisher 99-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Leona M. and Harry B. Helmsley Charitable Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Graft SurvivalIslets of Langerhans TransplantationGraft RejectionAdultHumansMaleCRISPR-Cas SystemsGene EditingInsulinInsulin-Secreting CellsTransplantation, HomologousClinical Trials, Phase I as TopicC-Peptide

Substanzen

InsulinC-Peptide

Autor:innen und Institutionen

  • Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
  • Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Sana Biotechnology, South San Francisco.
  • Department of Transplant Medicine, Oslo University Hospital, Oslo.
  • Section for Cellular Therapy, Oslo University Hospital, Oslo.
  • Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.

ORCID-Profile: Olle Korsgren

Förderung

  • Leona M. and Harry B. Helmsley Charitable Trust

Zitieren

APA

Carlsson, P. O., Hu, X., Scholz, H., Ingvast, S., Lundgren, T., Scholz, T., Eriksson, O., Liss, P., Yu, D., Deuse, T., Korsgren, O., & Schrepfer, S. (2025). Survival of Transplanted Allogeneic Beta Cells with No Immunosuppression. New England Journal of Medicine, 393(9), 887-894. https://doi.org/10.1056/nejmoa2503822

Vancouver

Carlsson PO, Hu X, Scholz H, Ingvast S, Lundgren T, Scholz T, et al. Survival of Transplanted Allogeneic Beta Cells with No Immunosuppression. New England Journal of Medicine. 2025;393(9):887-894. doi:10.1056/nejmoa2503822

BibTeX
@article{Carlsson2025,
  author = {Carlsson, Per-Ola and Hu, Xiaomeng and Scholz, Hanne and Ingvast, Sofie and Lundgren, Torbjörn and Scholz, Tim and Eriksson, Olof and Liss, Per and Yu, Di and Deuse, Tobias and Korsgren, Olle and Schrepfer, Sonja},
  title = {Survival of Transplanted Allogeneic Beta Cells with No Immunosuppression},
  journal = {New England Journal of Medicine},
  year = {2025},
  volume = {393},
  number = {9},
  pages = {887--894},
  doi = {10.1056/nejmoa2503822}
}
Kostenlos starten →